The Distinct Responsiveness of Cytokeratin 19-Positive Hepatocellular Carcinoma to Regorafenib

Regorafenib preferentially increased the growth inhibition and apoptosis of CK19+ cells in vitro, whereas sorafenib, apatinib, and 5-fluorouracil did not.